$ACAD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACADIA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACADIA PHARMACEUTICALS INC. Get notifications about new insider transactions in ACADIA PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 1.55 | 6,500 | 10,075 | 6,500 | 0 to 6.5 K |
| Dec 16 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 6.95 | 1,000 | 6,950 | 25,000 | |
| Dec 16 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 11,000 | 17,050 | 112,471 | |
| Dec 16 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 6.95 | 1,000 | 6,950 | 39,348 | 38.3 K to 39.3 K (+2.61 %) |
| Dec 16 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 11,000 | 17,050 | 38,348 | 27.3 K to 38.3 K (+40.22 %) |
| Dec 16 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 2,000 | 0 | 27,348 | 29.3 K to 27.3 K (-6.81 %) |
| Dec 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Option Exercise | M | 1.36 | 44,117 | 59,999 | 0 | ||
| Dec 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Sell | S | 23.41 | 44,117 | 1,032,911 | 0 | 44.1 K to 0 (-100.00 %) | |
| Dec 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Buy | M | 1.36 | 44,117 | 59,999 | 44,117 | 0 to 44.1 K | |
| Dec 04 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 2.00 | 15,000 | 30,000 | 0 | |
| Dec 04 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Sell | S | 23.45 | 15,000 | 351,807 | 109,049 | 124 K to 109 K (-12.09 %) |
| Dec 04 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 15,000 | 0 | 124,049 | 109 K to 124 K (+13.76 %) |
| Dec 04 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
| Dec 04 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 2.00 | 15,000 | 30,000 | 15,000 | 0 to 15 K |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Option Exercise | M | 1.30 | 37,692 | 49,000 | 0 | ||
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Sell | S | 23.00 | 37,692 | 867,033 | 8,500 | 46.2 K to 8.5 K (-81.60 %) | |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Buy | M | 1.30 | 37,692 | 49,000 | 46,192 | 8.5 K to 46.2 K (+443.44 %) | |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 2.00 | 15,000 | 30,000 | 15,000 | |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Sell | S | 23.24 | 15,000 | 348,638 | 109,049 | 124 K to 109 K (-12.09 %) |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 15,000 | 0 | 124,049 | 109 K to 124 K (+13.76 %) |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
| Nov 01 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 2.00 | 15,000 | 30,000 | 15,000 | 0 to 15 K |
| Oct 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Option Exercise | M | 1.30 | 10,000 | 13,000 | 0 | ||
| Oct 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Sell | S | 21.63 | 10,000 | 216,256 | 0 | 10 K to 0 (-100.00 %) | |
| Oct 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Buy | M | 1.30 | 10,000 | 13,000 | 10,000 | 0 to 10 K | |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 17,500 | 27,125 | 123,471 | |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 6.95 | 5,000 | 34,750 | 26,000 | |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 27.87 | 30,000 | 836,121 | 0 | 30 K to 0 (-100.00 %) |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 30,000 | 0 | 24,085 | 54.1 K to 24.1 K (-55.47 %) |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 17,500 | 27,125 | 54,085 | 36.6 K to 54.1 K (+47.83 %) |
| Oct 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 6.95 | 5,000 | 34,750 | 36,585 | 31.6 K to 36.6 K (+15.83 %) |
| Sep 20 2013 | ACAD | ACADIA PHARMACEUTI ... | Mills Roger | EVP, DEVELOPMENT AN ... | Option Exercise | M | 1.55 | 35,965 | 55,746 | 164,035 | |
| Sep 20 2013 | ACAD | ACADIA PHARMACEUTI ... | Mills Roger | EVP, DEVELOPMENT AN ... | Sell | S | 25.01 | 35,965 | 899,312 | 15,775 | 51.7 K to 15.8 K (-69.51 %) |
| Sep 20 2013 | ACAD | ACADIA PHARMACEUTI ... | Mills Roger | EVP, DEVELOPMENT AN ... | Buy | M | 0.00 | 35,965 | 0 | 51,740 | 15.8 K to 51.7 K (+227.99 %) |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Option Exercise | M | 1.30 | 45,500 | 59,150 | 29,500 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Option Exercise | M | 1.30 | 10,000 | 13,000 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Option Exercise | M | 6.10 | 4,500 | 27,450 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Sell | S | 22.92 | 60,000 | 1,375,470 | 13,500 | 73.5 K to 13.5 K (-81.63 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Buy | M | 1.30 | 45,500 | 59,150 | 73,500 | 28 K to 73.5 K (+162.50 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Buy | M | 1.30 | 10,000 | 13,000 | 28,000 | 18 K to 28 K (+55.56 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Buy | M | 6.10 | 4,500 | 27,450 | 18,000 | 13.5 K to 18 K (+33.33 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 2.16 | 34,722 | 75,000 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 2.16 | 10,000 | 21,600 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 9.04 | 10,000 | 90,400 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 8.85 | 5,084 | 44,993 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 8.85 | 6,500 | 57,525 | 0 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | M | 6.10 | 50 | 305 | 4,450 | ||
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Sell | S | 22.90 | 66,356 | 1,519,672 | 8,500 | 74.9 K to 8.5 K (-88.64 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 2.16 | 34,722 | 75,000 | 74,856 | 40.1 K to 74.9 K (+86.52 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 2.16 | 10,000 | 21,600 | 40,134 | 30.1 K to 40.1 K (+33.19 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 9.04 | 10,000 | 90,400 | 30,134 | 20.1 K to 30.1 K (+49.67 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 8.85 | 5,084 | 44,993 | 20,134 | 15.1 K to 20.1 K (+33.78 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 8.85 | 6,500 | 57,525 | 15,050 | 8.6 K to 15.1 K (+76.02 %) | |
| Sep 13 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Buy | M | 6.10 | 50 | 305 | 8,550 | 8.5 K to 8.6 K (+0.59 %) | |
| Sep 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Option Exercise | M | 1.30 | 46,153 | 59,999 | 0 | ||
| Sep 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Sell | S | 22.80 | 46,153 | 1,052,145 | 0 | 46.2 K to 0 (-100.00 %) | |
| Sep 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Buy | M | 1.30 | 46,153 | 59,999 | 46,153 | 0 to 46.2 K | |
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Option Exercise | M | 1.30 | 20,000 | 26,000 | 37,692 | ||
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Option Exercise | M | 1.30 | 10,000 | 13,000 | 0 | ||
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Option Exercise | M | 2.16 | 10,000 | 21,600 | 0 | ||
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Sell | S | 20.28 | 40,000 | 811,100 | 8,500 | 48.5 K to 8.5 K (-82.47 %) | |
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Buy | M | 1.30 | 20,000 | 26,000 | 48,500 | 28.5 K to 48.5 K (+70.18 %) | |
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Buy | M | 1.30 | 10,000 | 13,000 | 28,500 | 18.5 K to 28.5 K (+54.05 %) | |
| Sep 05 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Buy | M | 2.16 | 10,000 | 21,600 | 18,500 | 8.5 K to 18.5 K (+117.65 %) | |
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 8.49 | 10,000 | 84,900 | 0 | ||
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | M | 7.67 | 5,000 | 38,350 | 1,500 | ||
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Sell | S | 20.71 | 10,000 | 207,129 | 0 | 10 K to 0 (-100.00 %) | |
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Sell | S | 20.62 | 5,000 | 103,082 | 10,000 | 15 K to 10 K (-33.33 %) | |
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 8.49 | 10,000 | 84,900 | 15,000 | 5 K to 15 K (+200.00 %) | |
| Aug 28 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Buy | M | 7.67 | 5,000 | 38,350 | 5,000 | 0 to 5 K | |
| Aug 20 2013 | ACAD | ACADIA PHARMACEUTI ... | Moore Terrence O | EVP, CHIEF COMMERCI ... | Option Exercise | A | 19.61 | 150,000 | 2,941,500 | 150,000 | |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 1.08 | 17,771 | 19,193 | 0 | |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 1.08 | 35,000 | 37,800 | 0 | |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Sell | S | 20.14 | 52,771 | 1,063,061 | 109,049 | 161.8 K to 109 K (-32.61 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 52,771 | 0 | 161,820 | 109 K to 161.8 K (+48.39 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 52,771 | 0 | 0 | 52.8 K to 0 (-100.00 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 1.08 | 17,771 | 19,193 | 52,771 | 35 K to 52.8 K (+50.77 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 1.08 | 35,000 | 37,800 | 35,000 | 0 to 35 K |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 15,000 | 23,250 | 58,708 | |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 30,000 | 46,500 | 82,263 | |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 20.15 | 60,000 | 1,209,180 | 0 | 60 K to 0 (-100.00 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 60,000 | 0 | 31,585 | 91.6 K to 31.6 K (-65.51 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 15,000 | 23,250 | 91,585 | 76.6 K to 91.6 K (+19.59 %) |
| Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 30,000 | 46,500 | 76,585 | 46.6 K to 76.6 K (+64.40 %) |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Wells William McDowall | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | BORER MICHAEL T | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Brege Laura | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | GRAY MARY ANN | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | KAPLAN LESTER J PH D | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | A | 17.01 | 300,000 | 5,103,000 | 300,000 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | A | 17.01 | 175,000 | 2,976,750 | 175,000 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | A | 17.01 | 130,000 | 2,211,300 | 130,000 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Mills Roger | EVP, DEVELOPMENT AN ... | Option Exercise | A | 17.01 | 175,000 | 2,976,750 | 175,000 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Rasmussen Torsten | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Iversen Leslie L | Option Exercise | A | 17.01 | 14,000 | 238,140 | 14,000 | ||
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS ADVISORS LLC | Director | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS ADVISORS LLC | Director | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | |
| Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS ADVISORS LLC | Director | Option Exercise | A | 17.01 | 12,500 | 212,625 | 12,500 | |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 5,437 | 78,641 | 440,802 | 435.4 K to 440.8 K (+1.25 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 217,986 | 3,152,971 | 18,001,203 | 17.8 M to 18 M (+1.23 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 26,577 | 384,412 | 1,513,121 | 1.5 M to 1.5 M (+1.79 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.55 | 3,790 | 55,145 | 435,365 | 431.6 K to 435.4 K (+0.88 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.55 | 151,980 | 2,211,339 | 17,783,217 | 17.6 M to 17.8 M (+0.86 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.55 | 18,530 | 269,615 | 1,486,544 | 1.5 M to 1.5 M (+1.26 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.58 | 4,312 | 62,885 | 431,575 | 427.3 K to 431.6 K (+1.01 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.58 | 172,893 | 2,521,437 | 17,631,237 | 17.5 M to 17.6 M (+0.99 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.58 | 21,080 | 307,427 | 1,468,014 | 1.4 M to 1.5 M (+1.46 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 5,437 | 78,600 | 427,263 | 421.8 K to 427.3 K (+1.29 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 217,986 | 3,151,315 | 17,458,344 | 17.2 M to 17.5 M (+1.26 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.46 | 26,577 | 384,210 | 1,446,934 | 1.4 M to 1.4 M (+1.87 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.42 | 2,775 | 40,004 | 421,826 | 419.1 K to 421.8 K (+0.66 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.42 | 111,266 | 1,604,000 | 17,240,358 | 17.1 M to 17.2 M (+0.65 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.42 | 13,566 | 195,566 | 1,420,357 | 1.4 M to 1.4 M (+0.96 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.45 | 11,552 | 166,955 | 419,051 | 407.5 K to 419.1 K (+2.83 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.45 | 463,197 | 6,694,355 | 17,129,092 | 16.7 M to 17.1 M (+2.78 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.45 | 56,475 | 816,205 | 1,406,791 | 1.4 M to 1.4 M (+4.18 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.50 | 890 | 12,903 | 407,499 | 406.6 K to 407.5 K (+0.22 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.50 | 35,702 | 517,597 | 16,665,895 | 16.6 M to 16.7 M (+0.21 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.50 | 4,353 | 63,108 | 1,350,316 | 1.3 M to 1.4 M (+0.32 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.00 | 5,189 | 72,641 | 406,609 | 401.4 K to 406.6 K (+1.29 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.00 | 208,063 | 2,912,674 | 16,630,193 | 16.4 M to 16.6 M (+1.27 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.00 | 25,368 | 355,127 | 1,345,963 | 1.3 M to 1.3 M (+1.92 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.08 | 11,511 | 162,100 | 401,420 | 389.9 K to 401.4 K (+2.95 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.08 | 461,548 | 6,499,611 | 16,422,130 | 16 M to 16.4 M (+2.89 %) |
| Jun 05 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 14.08 | 56,274 | 792,462 | 1,320,595 | 1.3 M to 1.3 M (+4.45 %) |
| May 17 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 12.50 | 43,184 | 539,800 | 389,909 | 346.7 K to 389.9 K (+12.45 %) |
| May 17 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 12.50 | 1,730,970 | 21,637,125 | 15,960,582 | 14.2 M to 16 M (+12.16 %) |
| May 17 2013 | ACAD | ACADIA PHARMACEUTI ... | BAKER FELIX | Director | Buy | P | 12.50 | 218,846 | 2,735,575 | 1,264,321 | 1 M to 1.3 M (+20.93 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 1.08 | 20,449 | 22,085 | 35,000 | |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Option Exercise | M | 1.08 | 19,551 | 21,115 | 55,449 | |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Sell | S | 12.34 | 20,449 | 252,396 | 109,049 | 129.5 K to 109 K (-15.79 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 20,449 | 0 | 129,498 | 109 K to 129.5 K (+18.75 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 20,449 | 0 | 0 | 20.4 K to 0 (-100.00 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 1.08 | 20,449 | 22,085 | 20,449 | 0 to 20.4 K |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Sell | S | 12.71 | 19,551 | 248,519 | 109,049 | 128.6 K to 109 K (-15.20 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 19,551 | 0 | 128,600 | 109 K to 128.6 K (+17.93 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Gift | G | 0.00 | 19,551 | 0 | 0 | 19.6 K to 0 (-100.00 %) |
| May 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Hacksell Uli | CEO | Buy | M | 1.08 | 19,551 | 21,115 | 19,551 | 0 to 19.6 K |
| Apr 24 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.62 | 10,000 | 16,200 | 22,407 | |
| Apr 24 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Sell | S | 13.15 | 10,000 | 131,493 | 40,000 | 50 K to 40 K (-20.00 %) |
| Apr 24 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Buy | M | 1.62 | 10,000 | 16,200 | 50,000 | 40 K to 50 K (+25.00 %) |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.55 | 10,000 | 15,500 | 59,078 | |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.55 | 10,000 | 15,500 | 922 | |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.55 | 10,000 | 15,500 | 69,078 | |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.55 | 10,000 | 15,500 | 10,922 | |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Option Exercise | M | 1.55 | 10,000 | 15,500 | 79,078 | |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Sell | S | 12.26 | 10,000 | 122,600 | 40,000 | 50 K to 40 K (-20.00 %) |
| Apr 17 2013 | ACAD | ACADIA PHARMACEUTI ... | Baity Glenn | VP AND GC | Buy | M | 1.55 | 10,000 | 15,500 | 50,000 | 40 K to 50 K (+25.00 %) |